Bioresorbable Medical Material Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope
Bioresorbable medical materials refer to materials that are designed to be absorbed or broken down by the body over time. These materials are used in various medical applications, such as surgical implants and tissue engineering scaffolds, that offer several advantages over permanent implants and eliminate the need for surgical removal once the desired function is achieved.

Sizing and Forecast
The bioresorbable medical material market size has grown rapidly in recent years. It will grow from $1.4 billion in 2023 to $1.55 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to traditional non-resorbable materials limitations, advancements in polymer science, surge in cardiovascular interventions, growing aging population, expansion of minimally invasive surgeries.

The bioresorbable medical material market size is expected to see strong growth in the next few years. It will grow to $2.24 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing demand for bioresorbable scaffolds, adoption of bioresorbable materials in various medical applications, rise in cardiovascular and orthopedic procedures, growing focus on patient comfort and recovery, expanding applications in tissue engineering. Major trends in the forecast period include customization of bioresorbable materials for specific medical applications, integration of bioresorbable materials in drug delivery systems, growth of 3d printing in bioresorbable medical device manufacturing, development of combination products with bioresorbable elements, emphasis on sustainable and environmentally friendly medical materials,.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/bioresorbable-medical-material-global-market-report

Segmentation & Regional Insights
The bioresorbable medical material market covered in this report is segmented –

1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA)
2) By Application: Drug Delivery, Orthopedics, Other Applications
3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users

North America was the largest region in the bioresorbable medical material market in 2023. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12219&type=smp

Major Driver Impacting Market Growth
The increasing number of surgeries is expected to propel the growth of the bioresorbable medical material market going forward. Surgical procedures refer to medical treatment that involves making an incision and using tools to stop or repair disease in a living body. Bioresorbable polymers are used in molded medical equipment, particularly those used in neurology, orthopedics, and cosmetic surgery. Bioresorbable materials can be used to make sutures, anchors, and screws. For instance, in 2022, according to the British Heart Foundation, a UK-based cardiovascular research charity. states that in UK surgical procedures, transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI) surgeries, increased from 5,676 in 2019/20 to 6,328 in 2020/21. Therefore, the increasing number of surgeries is driving the growth of the bioresorbable medical material market.

Key Industry Players
Major companies operating in the bioresorbable medical material market report are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., COFCO Biotechnology Co. Ltd., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., Shenzhen eSUN Industrial Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.

The bioresorbable medical material market report table of contents includes:

1. Executive Summary
2. Bioresorbable Medical Material Market Characteristics
3. Bioresorbable Medical Material Market Trends And Strategies
4. Bioresorbable Medical Material Market – Macro Economic Scenario
5. Global Bioresorbable Medical Material Market Size and Growth
.
.
.
32. Global Bioresorbable Medical Material Market Competitive Benchmarking
33. Global Bioresorbable Medical Material Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Bioresorbable Medical Material Market
35. Bioresorbable Medical Material Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model